zLOCK
Commercial- Indications
- Spinal fusion, Back pain
Company intelligence / Profile preview
ZygoFix’s zLOCK system is a minimally invasive, screwless spinal implant designed to stabilize the facet joint for lumbar fusion. Clinical studies in Europe since 2018 have shown long-term pain reduction and radiographic evidence of bone growth. The device received FDA clearance in May 2024 based on compelling clinical evidence from European trials. The technology reduces surgical trauma, procedure time, and risk of complications compared to traditional pedicle screw systems.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZygoFix.